The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma

por Dibajnia, Pooya, Cardenas, Luisa M., Lalani, Aly-Khan A.
Publicado 2023

Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report

por Bondy, Suraya, Tajzler, Camilla, Hotte, Sebastien J., Kapoor, Anil, Zbuk, Kevin, Lalani, Aly-Khan A.
Publicado 2020

Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma

por Cardenas, Luisa M., Deluce, Jasna E., Khan, Shahrukh, Gulam, Omar, Maleki Vareki, Saman, Fernandes, Ricardo, Lalani, Aly-Khan A.
Publicado 2022

Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review

por Lalani, Aly-Khan A., Heng, Daniel Y. C., Basappa, Naveen S., Wood, Lori, Iqbal, Nayyer, McLeod, Deanna, Soulières, Denis, Kollmannsberger, Christian
Publicado 2022

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series

por Martini, Dylan J., Lalani, Aly-Khan A., Bossé, Dominick, Steinharter, John A., Harshman, Lauren C., Hodi, F. Stephen, Ott, Patrick A., Choueiri, Toni K.
Publicado 2017

Pan-urologic cancer genomic subtypes that transcend tissue of origin

por Chen, Fengju, Zhang, Yiqun, Bossé, Dominick, Lalani, Aly-Khan A., Hakimi, A. Ari, Hsieh, James J., Choueiri, Toni K., Gibbons, Don L., Ittmann, Michael, Creighton, Chad J.
Publicado 2017

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma

por Bellmunt, Joaquim, Lalani, Aly-Khan A., Jacobus, Sussana, Wankowicz, Stephanie A., Polacek, Laura, Takeda, David Y., Harshman, Lauren C., Wagle, Nikhil, Moreno, Irene, Lundgren, Kevin, Bossé, Dominick, Van Allen, Eliezer M., Choueiri, Toni K., Rosenberg, Jonathan E.
Publicado 2018

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

por Lalani, Aly-Khan A., Gray, Kathryn P., Albiges, Laurence, Callea, Marcella, Pignon, Jean-Christophe, Pal, Soumitro, Gupta, Mamta, Bhatt, Rupal S., McDermott, David F., Atkins, Michael B., Woude, G.F. Vande, Harshman, Lauren C., Choueiri, Toni K., Signoretti, Sabina
Publicado 2017

Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System

por Cardenas, Luisa M., Ghosh, Sunita, Finelli, Antonio, Wood, Lori, Kollmannsberger, Christian, Basappa, Naveen, Graham, Jeffrey, Heng, Daniel, Bjarnason, Georg, Soulières, Denis, Bossé, Dominick, Castonguay, Vincent, Saleh, Ramy, Tanguay, Simon, Bhindi, Bimal, Breau, Rodney H., Pouliot, Frederic, Lalani, Aly-Khan A.
Publicado 2023

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

por Lalani, Aly-Khan A., Xie, Wanling, Martini, Dylan J., Steinharter, John A., Norton, Craig K., Krajewski, Katherine M., Duquette, Audrey, Bossé, Dominick, Bellmunt, Joaquim, Van Allen, Eliezer M., McGregor, Bradley A., Creighton, Chad J., Harshman, Lauren C., Choueiri, Toni K.
Publicado 2018

Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma

por Parmar, Ambica, Ghosh, Sunita, Sahgal, Arjun, Lalani, Aly‐Khan A., Hansen, Aaron R., Reaume, M. Neil, Wood, Lori, Basappa, Naveen S., Heng, Daniel Y. C., Graham, Jeffrey, Kollmannsberger, Christian, Soulières, Denis, Breau, Rodney H., Tanguay, Simon, Kapoor, Anil, Pouliot, Frédéric, Bjarnason, Georg A.
Publicado 2022

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma

por de Velasco, Guillermo, Wankowicz, Stephanie A., Madison, Russell, Ali, Siraj M., Norton, Craig, Duquette, Audrey, Ross, Jeffrey S., Bossé, Dominick, Lalani, Aly-Khan A., Miller, Vincent A., Stephens, Philip J., Young, Lauren, Hakimi, A. Ari, Signoretti, Sabina, Pal, Sumanta K., Choueiri, Toni K.
Publicado 2018

Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System

por Nguyen, Eric K., Lalani, Aly Khan A., Ghosh, Sunita, Basappa, Naveen S., Kapoor, Anil, Hansen, Aaron R., Kollmannsberger, Christian, Heng, Daniel, Wood, Lori A., Castonguay, Vincent, Soulières, Denis, Winquist, Eric, Canil, Christina, Graham, Jeffrey, Bjarnason, Georg A., Breau, Rodney H., Pouliot, Frédéric, Swaminath, Anand
Publicado 2022

Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts

por Bossé, Dominick, Xie, Wanling, Lin, Xun, Simantov, Ronit, Lalani, Aly-Khan A., Graham, Jeffrey, Wells, J. Connor, Donskov, Frede, Rini, Brian, Beuselinck, Benoit, Alva, Ajjai, Hansen, Aaron, Wood, Lori, Soulières, Denis, Kollmannsberger, Christian, Patenaude, Francois, Heng, Daniel Y.C., Choueiri, Toni K., McKay, Rana R.
Publicado 2020

Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase...

por Bilen, Mehmet A., Rini, Brian I., Voss, Martin H., Larkin, James, Haanen, John B.A.G., Albiges, Laurence, Pagliaro, Lance C., Voog, Eric G., Lam, Elaine T., Kislov, Nikolay, McGregor, Bradley A., Lalani, Aly-Khan A., Huang, Bo, di Pietro, Alessandra, Krulewicz, Stan, Robbins, Paul B., Choueiri, Toni K.
Publicado 2022

Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Rena...

por Gan, Chun Loo, Dudani, Shaan, Wells, J. Connor, Donskov, Frede, Pal, Sumanta K., Dizman, Nazli, Rathi, Nityam, Beuselinck, Benoit, Yan, Flora, Lalani, Aly‐Khan A., Hansen, Aaron, Szabados, Bernadett, de Velasco, Guillermo, Tran, Ben, Lee, Jae Lyun, Vaishampayan, Ulka N., Bjarnason, Georg A., Subasri, Mathushan, Choueiri, Toni K., Heng, Daniel Y. C.
Publicado 2021

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

por Rosenberg, Jonathan E., Hahn, Noah M., Regan, Meredith M., Werner, Lillian, Alva, Ajjai, George, Saby, Picus, Joel, Alter, Robert, Balar, Arjun, Hoffman-Censits, Jean, Grivas, Petros, Lauer, Richard, Guancial, Elizabeth A., Hoimes, Christopher, Sonpavde, Guru, Albany, Constantine, Stein, Mark N., Breen, Tim, Jacobs, Cindy, Anderson, Kirsten, Bellmunt, Joaquim, Lalani, Aly-Khan A., Pal, Sumanta, Choueiri, Toni K.
Publicado 2018

Metabolomic adaptations and correlates of survival to immune checkpoint blockade

por Li, Haoxin, Bullock, Kevin, Gurjao, Carino, Braun, David, Shukla, Sachet A., Bossé, Dominick, Lalani, Aly-Khan A., Gopal, Shuba, Jin, Chelsea, Horak, Christine, Wind-Rotolo, Megan, Signoretti, Sabina, McDermott, David F., Freeman, Gordon J., Van Allen, Eliezer M., Schreiber, Stuart L., Stephen Hodi, F., Sellers, William R., Garraway, Levi A., Clish, Clary B., Choueiri, Toni K., Giannakis, Marios
Publicado 2019